Structural sleuthing salvages superbug slayer

After failing to make the superbug-fighting molecule baulamycin, UK researchers have overturned the chemical structure it was originally assigned. Varinder Aggarwal and colleagues at the University of Bristol had been trying to make both baulamycin A and B using the ‘assembly line synthesis’ approach they developed. But the method would also provide answers to a challenge arising from the baulamycins’ exotic origins.